VBI Vaccines
VBIV
#10524
Rank
S$2.41 M
Marketcap
S$0.08432
Share price
0.00%
Change (1 day)
-89.86%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): S-$13.65

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is S-$13.09. In 2022 the company made an earnings per share (EPS) of S-$17.05 a decrease over its 2021 EPS that were of S-$10.46.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$13.65
2022S-$17.0562.96%
2021S-$10.4628.57%
2020S-$8.14-54.35%
2019S-$17.82-52.58%
2018S-$37.5810.23%
2017S-$34.0914.29%
2016S-$29.83-62.8%
2015S-$80.1990.68%
2014S-$42.06-7.95%
2013S-$45.69-57.97%
2012S-$108.72-78%
2011S-$494.253151.47%
2010S-$15.2023.87%
2009S-$12.27-18.48%
2008S-$15.0512.08%
2007S-$13.43-49.47%
2006S-$26.58
2005N/A-100%
2004S-$11.8211.94%
2003S-$10.56-81.89%
2002S-$58.30196.44%
2001S-$19.6684.33%
2000S-$10.67-65.37%
1999S-$30.81-29.45%
1998S-$43.6729.61%
1997S-$33.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
S-$1.23-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
S-$5.59-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
S-$4.74-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA